Literature DB >> 22281578

Science funding: Provocative questions in cancer research.

Harold Varmus1, Ed Harlow.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22281578     DOI： 10.1038/481436a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  Public health. Grand Challenges in Global Health.

Authors:  H Varmus; R Klausner; E Zerhouni; T Acharya; A S Daar; P A Singer
Journal:  Science       Date:  2003-10-17       Impact factor: 47.728

Review 2.  Cancer therapy based on oncogene addiction.

Authors:  Frank McCormick
Journal:  J Surg Oncol       Date:  2011-05-01       Impact factor: 3.454

Review 3.  Interpreting the epidemiological evidence linking obesity and cancer: A framework for population-attributable risk estimations in Europe.

Authors:  Andrew G Renehan; Isabelle Soerjomataram; Michael F Leitzmann
Journal:  Eur J Cancer       Date:  2010-09       Impact factor: 9.162

4.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

5.  Long-term mortality after gastric bypass surgery.

Authors:  Ted D Adams; Richard E Gress; Sherman C Smith; R Chad Halverson; Steven C Simper; Wayne D Rosamond; Michael J Lamonte; Antoinette M Stroup; Steven C Hunt
Journal:  N Engl J Med       Date:  2007-08-23       Impact factor: 91.245

Review 6.  Scientists and clinicians test their metal-back to the future with platinum compounds.

Authors:  Alexander D Guminski; Paul R Harnett; Anna deFazio
Journal:  Lancet Oncol       Date:  2002-05       Impact factor: 41.316
  6 in total
  15 in total

1.  Diabetes, Abnormal Glucose, Dyslipidemia, Hypertension, and Risk of Inflammatory and Other Breast Cancer.

Authors:  Catherine Schairer; Shahinaz M Gadalla; Ruth M Pfeiffer; Steven C Moore; Eric A Engels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-01-13       Impact factor: 4.254

Review 2.  Provocative questions in cancer epidemiology in a time of scientific innovation and budgetary constraints.

Authors:  Tram Kim Lam; Sheri D Schully; Scott D Rogers; Rachel Benkeser; Britt Reid; Muin J Khoury
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-02-14       Impact factor: 4.254

3.  Decade in review-funding in cancer research: National Cancer Institute awards-a work in progress.

Authors:  Tito Fojo; Paraskevi Giannakakou
Journal:  Nat Rev Clin Oncol       Date:  2014-10-14       Impact factor: 66.675

Review 4.  Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology.

Authors:  S Ogino; P Lochhead; E Giovannucci; J A Meyerhardt; C S Fuchs; A T Chan
Journal:  Oncogene       Date:  2013-06-24       Impact factor: 9.867

5.  GUCY2C: at the intersection of obesity and cancer.

Authors:  Gilbert W Kim; Jieru E Lin; Scott A Waldman
Journal:  Trends Endocrinol Metab       Date:  2013-01-29       Impact factor: 12.015

6.  Obesity and related conditions and risk of inflammatory breast cancer: a nested case-control study.

Authors:  Catherine Schairer; Cecile A Laurent; Lisa M Moy; Gretchen L Gierach; Neil E Caporaso; Ruth M Pfeiffer; Lawrence H Kushi
Journal:  Breast Cancer Res Treat       Date:  2020-07-20       Impact factor: 4.872

7.  Quantifying the Role of Circulating Unconjugated Estradiol in Mediating the Body Mass Index-Breast Cancer Association.

Authors:  Catherine Schairer; Barbara J Fuhrman; Jennifer Boyd-Morin; Jeanine M Genkinger; Mitchell H Gail; Robert N Hoover; Regina G Ziegler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-12-04       Impact factor: 4.254

8.  First International Workshopson Provocative Questions (PQ) in Cancer Research, October-November 2014, New Delhi, Bengaluru, and Thiruvananthapuram, India.

Authors:  Preetha Rajaraman; Bindu Dey; Partha P Majumder; Satyajit Mayor; M Radhakrishna Pillai; S Ramaswamy; Chandrima Shaha; Maureen Johnson; Sudha Sivaram; Edward L Trimble; Edward E Harlow; K VijayRaghavan
Journal:  J Cancer Policy       Date:  2015-12-01

Review 9.  Overlapping biomarkers, pathways, processes and syndromes in lymphatic development, growth and neoplasia.

Authors:  Marlys H Witte; Michael T Dellinger; Cristobal M Papendieck; Francesco Boccardo
Journal:  Clin Exp Metastasis       Date:  2012-07-15       Impact factor: 5.150

Review 10.  The Enigmatic Role of TP53 in Germ Cell Tumours: Are We Missing Something?

Authors:  Margaret Ottaviano; Emilio Francesco Giunta; Pasquale Rescigno; Ricardo Pereira Mestre; Laura Marandino; Marianna Tortora; Vittorio Riccio; Sara Parola; Milena Casula; Panagiotis Paliogiannis; Antonio Cossu; Ursula Maria Vogl; Davide Bosso; Mario Rosanova; Brunello Mazzola; Bruno Daniele; Giuseppe Palmieri; Giovannella Palmieri
Journal:  Int J Mol Sci       Date:  2021-07-02       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.